The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
13
ILEOCECAL RESECTION FOR RECENTLY DIAGNOSED ILEOCECAL CROHN’S DISEASE IS ASSOCIATED WITH IMPROVED LONG-TERM OUTCOMES COMPARED TO ANTI-TUMOR NECROSIS FACTOR THERAPY: A POPULATION-BASED STUDY
Date
May 6, 2023
Explore related products in the following collection:
BACKGROUND AND AIMS: A treat-to-target (TTT) strategy of striving for symptomatic and endoscopic remission is recommended for the management of inflammatory bowel diseases (IBD). Yet, real-world uptake of TTT strategies has been modest…
The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
The burden of IBD is rising globally. This session aims to understand the role of genetics in the development of IBD in diverse populations and define the pre-disease state in IBD. It will also explore the emerging field of multi-omics to clinically characterize IBD…
Aconitate decarboxylase 1 (ACOD1; also known as IRG-1) is the ubiquitous source of the metabolite itaconate, which dampens inflammasome activation by preventing HIF1α production of IL-1β and prevents TNF production through NRF2 activation…